ATE406874T1 - Zusammensetzungen und verfahren zur stabilisierung von adjuvans-formulierungen auf lipid-basis unter verwendung von glykolipiden - Google Patents
Zusammensetzungen und verfahren zur stabilisierung von adjuvans-formulierungen auf lipid-basis unter verwendung von glykolipidenInfo
- Publication number
- ATE406874T1 ATE406874T1 AT05756461T AT05756461T ATE406874T1 AT E406874 T1 ATE406874 T1 AT E406874T1 AT 05756461 T AT05756461 T AT 05756461T AT 05756461 T AT05756461 T AT 05756461T AT E406874 T1 ATE406874 T1 AT E406874T1
- Authority
- AT
- Austria
- Prior art keywords
- glycolipides
- compositions
- methods
- based adjuvant
- adjuvant formulations
- Prior art date
Links
- 239000002671 adjuvant Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000000087 stabilizing effect Effects 0.000 title 1
- 239000002502 liposome Substances 0.000 abstract 4
- 229930186217 Glycolipid Natural products 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200401070 | 2004-07-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE406874T1 true ATE406874T1 (de) | 2008-09-15 |
Family
ID=34982425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05756461T ATE406874T1 (de) | 2004-07-07 | 2005-07-05 | Zusammensetzungen und verfahren zur stabilisierung von adjuvans-formulierungen auf lipid-basis unter verwendung von glykolipiden |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1765289B1 (de) |
JP (1) | JP4987704B2 (de) |
KR (1) | KR101275837B1 (de) |
CN (1) | CN1980638B (de) |
AT (1) | ATE406874T1 (de) |
AU (1) | AU2005259685B2 (de) |
BR (1) | BRPI0512757B8 (de) |
CA (1) | CA2572985C (de) |
DE (1) | DE602005009535D1 (de) |
DK (1) | DK1765289T3 (de) |
ES (1) | ES2315880T3 (de) |
PL (1) | PL1765289T3 (de) |
PT (1) | PT1765289E (de) |
SI (1) | SI1765289T1 (de) |
WO (1) | WO2006002642A2 (de) |
ZA (1) | ZA200701043B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008000261A2 (en) * | 2006-06-28 | 2008-01-03 | Statens Serum Institut | Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
ES2611924T3 (es) | 2006-10-03 | 2017-05-11 | Arbutus Biopharma Corporation | Formulaciones que contienen lípidos |
PL2167124T3 (pl) | 2007-06-29 | 2012-12-31 | Statens Seruminstitut | Zastosowanie monomikoliloglicerolu (MMG) jako adiuwantu |
US20110280930A1 (en) | 2008-05-02 | 2011-11-17 | Facundo Batista | Products and methods for stimulating an immune response |
PT2385980T (pt) * | 2009-01-08 | 2018-06-26 | Albert Einstein College Medicine Inc | Vacinas bacterianas com glicolípidos do tipo ceramida associados à parede celular e utilização dos mesmos |
CN102482666B (zh) * | 2009-07-06 | 2017-02-08 | 变异生物技术公司 | 制备囊泡的方法和由其产生的制剂 |
JP5933538B2 (ja) * | 2010-07-02 | 2016-06-08 | インターベット インターナショナル ベー. フェー. | エーリキア・カニスに対するワクチンおよび関連する方法 |
US20140112979A1 (en) | 2011-07-04 | 2014-04-24 | Statens Serum Institut | Methods for producing liposomes |
JP6182457B2 (ja) * | 2011-12-12 | 2017-08-16 | 協和発酵キリン株式会社 | カチオン性脂質を含有するドラックデリバリーシステムのための脂質ナノ粒子 |
WO2013089152A1 (ja) * | 2011-12-12 | 2013-06-20 | 協和発酵キリン株式会社 | カチオン性脂質の組み合わせを含有する脂質ナノ粒子 |
JP2016175841A (ja) * | 2013-08-02 | 2016-10-06 | 三郎 斎藤 | リポソームと、細胞障害性t細胞活性を誘導するワクチン組成物 |
BR112016005948A2 (pt) * | 2013-09-19 | 2017-09-26 | Zoetis Services Llc | adjuvantes com base em óleo |
CN106535933B (zh) * | 2014-08-04 | 2021-09-17 | 日东电工株式会社 | 包含核受体配体的免疫诱导促进用组合物以及疫苗药物组合物 |
BR112018001318B1 (pt) * | 2015-07-20 | 2023-11-14 | Zoetis Services Llc | Lipossoma livre de saponina, formulação adjuvante, composição de vacina, uso terapêutico de um componente antigênico e da formulação adjuvante e método para preparar o referido lipossoma |
US12064480B2 (en) | 2018-04-13 | 2024-08-20 | Glaxosmithkline Biologicals Sa | Immunigenic alpha-branched trehalose-diesters |
CN114657147B (zh) * | 2022-01-27 | 2023-12-01 | 安徽智飞龙科马生物制药有限公司 | 一种生物材料的保护剂及其应用 |
CN115068602B (zh) * | 2022-08-22 | 2022-11-01 | 北京华诺泰生物医药科技有限公司 | 一种表面改性氧化铝的复合疫苗佐剂、制备方法及应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5108934A (en) * | 1983-11-30 | 1992-04-28 | Kabushiki Kaisha Toshiba | Quantitative immunoassay utilizing liposomes |
JP2714972B2 (ja) * | 1988-02-02 | 1998-02-16 | 千葉製粉株式会社 | リン脂質集合体用修飾剤、リン脂質小胞体用凝集防止剤、リン脂質小胞体用融合防止剤およびリン脂質膜用表面固定化剤 |
JPH03249561A (ja) * | 1990-02-28 | 1991-11-07 | Toshiba Corp | 免疫分析試薬 |
JPH0482824A (ja) * | 1990-07-23 | 1992-03-16 | Nippon Oil & Fats Co Ltd | リポソーム及び水中油型エマルション |
JPH0616688A (ja) * | 1992-06-30 | 1994-01-25 | Nippon Oil & Fats Co Ltd | 脂肪酸糖エステル |
JP3884488B2 (ja) * | 1993-03-10 | 2007-02-21 | 千葉製粉株式会社 | オリゴ糖脂質 |
JP3329554B2 (ja) * | 1993-03-10 | 2002-09-30 | 千葉製粉株式会社 | 乾燥小胞体 |
US5885613A (en) * | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
JPH0925287A (ja) * | 1995-07-13 | 1997-01-28 | Eisai Co Ltd | 合成脂質 |
JPH09110722A (ja) * | 1995-10-20 | 1997-04-28 | Toray Ind Inc | 抗腫瘍活性物質の腫瘍細胞内導入用イムノリポソーム及びその調製法 |
US6183774B1 (en) * | 1996-01-31 | 2001-02-06 | Collaborative Laboratories, Inc. | Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts |
US6210707B1 (en) * | 1996-11-12 | 2001-04-03 | The Regents Of The University Of California | Methods of forming protein-linked lipidic microparticles, and compositions thereof |
GB9808268D0 (en) * | 1998-04-17 | 1998-06-17 | Imp College Innovations Ltd | Compound |
GB0007150D0 (en) * | 2000-03-24 | 2000-05-17 | Lamellar Therapeutics Limited | Immunotherapeutic methods and compositions |
AU2002311616B2 (en) * | 2001-06-25 | 2007-11-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | A method for preparation of vesicles loaded with biological material and different uses thereof |
-
2005
- 2005-07-05 ES ES05756461T patent/ES2315880T3/es active Active
- 2005-07-05 JP JP2007519615A patent/JP4987704B2/ja active Active
- 2005-07-05 DE DE602005009535T patent/DE602005009535D1/de active Active
- 2005-07-05 WO PCT/DK2005/000467 patent/WO2006002642A2/en active Application Filing
- 2005-07-05 AU AU2005259685A patent/AU2005259685B2/en active Active
- 2005-07-05 SI SI200530467T patent/SI1765289T1/sl unknown
- 2005-07-05 PL PL05756461T patent/PL1765289T3/pl unknown
- 2005-07-05 EP EP05756461A patent/EP1765289B1/de active Active
- 2005-07-05 BR BRPI0512757A patent/BRPI0512757B8/pt active IP Right Grant
- 2005-07-05 CA CA2572985A patent/CA2572985C/en active Active
- 2005-07-05 AT AT05756461T patent/ATE406874T1/de active
- 2005-07-05 PT PT05756461T patent/PT1765289E/pt unknown
- 2005-07-05 DK DK05756461T patent/DK1765289T3/da active
- 2005-07-05 CN CN200580022926XA patent/CN1980638B/zh active Active
- 2005-07-05 KR KR1020077002648A patent/KR101275837B1/ko active IP Right Review Request
-
2007
- 2007-02-05 ZA ZA200701043A patent/ZA200701043B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006002642A2 (en) | 2006-01-12 |
ZA200701043B (en) | 2007-12-27 |
KR101275837B1 (ko) | 2013-06-18 |
KR20070051847A (ko) | 2007-05-18 |
AU2005259685A1 (en) | 2006-01-12 |
CN1980638A (zh) | 2007-06-13 |
JP4987704B2 (ja) | 2012-07-25 |
CN1980638B (zh) | 2011-10-12 |
CA2572985A1 (en) | 2006-01-12 |
BRPI0512757A (pt) | 2008-04-08 |
PL1765289T3 (pl) | 2009-02-27 |
AU2005259685B2 (en) | 2010-04-08 |
BRPI0512757B8 (pt) | 2021-05-25 |
EP1765289B1 (de) | 2008-09-03 |
SI1765289T1 (sl) | 2009-02-28 |
CA2572985C (en) | 2014-04-22 |
EP1765289A2 (de) | 2007-03-28 |
DK1765289T3 (da) | 2008-12-15 |
JP2008505131A (ja) | 2008-02-21 |
ES2315880T3 (es) | 2009-04-01 |
PT1765289E (pt) | 2008-12-05 |
WO2006002642A3 (en) | 2006-05-18 |
BRPI0512757B1 (pt) | 2021-04-06 |
DE602005009535D1 (de) | 2008-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE406874T1 (de) | Zusammensetzungen und verfahren zur stabilisierung von adjuvans-formulierungen auf lipid-basis unter verwendung von glykolipiden | |
WO2021155243A8 (en) | Respiratory virus immunizing compositions | |
ATE272410T1 (de) | Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe | |
ATE503493T1 (de) | Influenza vakzinzusammensetzungen zur intradermaler verabreichung | |
TW200642700A (en) | Chemically defined stabiliser | |
MX2009008928A (es) | Composiciones que comprenden conjugados de polisacaridos y su uso como vacunas. | |
RU2013114392A (ru) | Маленькие липосомы для доставки кодирующей иммуноген рнк | |
MX358706B (es) | Moleculas de acido nucleico artificiales que comprenden un top 5´utr. | |
ME01965B (me) | Stabilizatori za vakcine osušene zamrzavanjem | |
WO2011027257A3 (en) | Pcsk9 vaccine | |
MX2010012999A (es) | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. | |
WO2007024941A3 (en) | Polyvalent vaccine | |
WO2010019262A3 (en) | Polyvalent vaccine | |
GB2386072A (en) | Novel vaccine | |
MX2010009351A (es) | Particulas similares a virus cristalizadas con azucar. | |
TW200510538A (en) | Functionally reconstituted viral membranes containing adjuvant | |
ZA202101465B (en) | Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery | |
MX2011007692A (es) | Vacunas mejoradas para el virus del papiloma humano y procedimientos para su utilizacion. | |
PH12018500458A1 (en) | Vlp stabilized vaccine compositions | |
EA201391456A1 (ru) | ВАКЦИНА ПРОТИВ Streptococcus pneumoniae | |
WO2011032108A3 (en) | Formulation for room temperature stabilization of a live attenuated bacterial vaccine | |
DE60336588D1 (de) | Verbesserte anthraximpfstoffe und abgabeverfahren | |
ATE404174T1 (de) | Impfstoff zur transmukosalen verabreichung | |
WO2023235660A3 (en) | Flavivirus immunogens and vaccine compositions and methods of using the same | |
WO2003101482A3 (en) | Liposome vaccine formulations for fin-fish |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1765289 Country of ref document: EP |